Is the mandate of the Patented Medicines Prices Review Board (PMPRB) to protect Canadian consumers by ensuring that prices charged by manufacturers for patented medicines are not excessive and, if so, is the PMPRB exceeding its mandate by regulating prices of patented medicines that are being sold to non-Canadians outside Canada?
In the House of Commons on November 4th, 2005. See this statement in context.